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Abstract
The increasing antibiotic resistance in bacterial populations requires alternatives for classical treatment of infectious
diseases and therefore drives the renewed interest in phage therapy. Methicillin resistant Staphylococcus aureus (MRSA) is a
major problem in health care settings and live-stock breeding across the world. This research aims at a thorough
microbiological, genomic, and proteomic characterization of S. aureus phage ISP, required for therapeutic applications. Host
range screening of a large batch of S. aureus isolates and subsequent fingerprint and DNA microarray analysis of the isolates
revealed a substantial activity of ISP against 86% of the isolates, including relevant MRSA strains. From a phage therapy
perspective, the infection parameters and the frequency of bacterial mutations conferring ISP resistance were determined.
Further, ISP was proven to be stable in relevant in vivo conditions and subcutaneous as well as nasal and oral ISP
administration to rabbits appeared to cause no adverse effects. ISP encodes 215 gene products on its 138,339 bp genome,
22 of which were confirmed as structural proteins using tandem electrospray ionization-mass spectrometry (ESI-MS/MS),
and shares strong sequence homology with the ‘Twort-like viruses’. No toxic or virulence-associated proteins were
observed. The microbiological and molecular characterization of ISP supports its application in a phage cocktail for
therapeutic purposes.
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Introduction
The scientific reappraisal of the use of bacteriophages in the
treatment of bacterial infections is reflected by hundreds of phage
therapy-related publications in the last decade. However, so far,
no phage preparation has been approved for market authoriza-
tion. In 2009, Merabishvili et al. [1] evaluated the safety and
efficacy of bacteriophage therapy with the standardized quality-
controlled small-scale production of the phage cocktail BFC-1.
This cocktail contains two phages, 14/1 and PNM, infecting
Pseudomonas aeruginosa, and one phage infecting Staphylococcus aureus,
both frequent pathogens in burn wound infections. The S. aureus-
infecting phage in BFC-1 is ISP, a member of the Myoviridae and
closely related to phage G1 [2]. ISP was originally isolated in the
1920s from an unknown source in Tbilisi (Georgia) by the Eliava
Institute of Bacteriophage, Microbiology and Virology and was
selected as a therapeutic phage based on a host range study on
burn wound isolates. The physicochemical properties and the
pyrogenicity of the phage cocktail, and hence of the ISP
preparation, are conform to the European Pharmacopoeia
standards and show no cytotoxicity towards human neonatal
foreskin keratinocytes. The quality control of BFC-1 also
confirmed the absence of temperate bacteriophages and verified
the presence of the expected virion morphology as well as the
specific interaction with the target bacteria [1].
In this paper, we present the complete microbiological and
molecular examination of this therapeutically important phage,
which includes stability assays, genome and virion analysis and an
extensive host range screening.
Analysis
ISP host range screening and analysis of the
Staphylococcus host collection
High-titer ISP stocks were obtained through amplification in
liquid Mueller Hinton medium using S. aureus subsp. aureus
Rosenbach ATCC 6538 (further referred to as ‘strain ATCC
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6538’). Subsequent purification and concentration of the phage
was performed by CsCl density gradient centrifugation following
polyethylene glycol 8000 precipitation [3].
Phage ISP was subjected to a host screening involving 86 S.
aureus strains and nine S. haemolyticus isolates (Table S1). These
isolates have a different origin, ranging from human and animal
isolates to propagation strains for typing phages. All isolates were
typed using automated repetitive sequence-based PCR (rep-PCR)
DNA fingerprinting. Therefore, bacterial DNA was isolated with
the UltraCleanTM Microbial DNA Isolation Kit (MO Bio
Laboratories, Carlsbad, USA) and rep-PCR was performed using
the DiversiLabTM DNA Staphylococcus fingerprinting Kit (bioMe´r-
ieux, Brussels, Belgium). In a next step, rep-PCR profiles were
obtained using the microfluidic DNA chips (DiversiLabTM
LabChip, bioMe´rieux) and an Agilent 2100 BioAnalyzer (Agilent
Technologies, USA) according to the manufacturer’s instructions.
The resulting rep-PCR fingerprinting profiles were compared
using the web-based DiversiLab software (bioMe´rieux), version
3.3. The S. aureus and S. haemolyticus isolates were clustered into 22
genotypes (98% similarity) (Figure 1). The S. aureus and the S.
haemolyticus isolates are clearly clustered separately. Further, the
human clinical S. aureus isolates (N = 34) and the phage
propagation strains (N = 31) were quite randomly distributed over
14 clusters. The horse (N = 6), pig (N = 3) and poultry (N = 5)
isolates grouped into two closely related clusters and the rabbit
(N = 7) isolates clustered together with two phage propagation
strains.
For a subset of human and animal isolates, the presence of genes
encoding resistance to commonly used antimicrobial agents was
determined with DNA array hybridization using the Staphy-
Type96 Kit (Alere Technologies GmbH, Jena, Germany) (Table
S1). All tested isolates carry tetracycline resistance genes and all
but one isolate encode methicillin resistance and penicillinase
genes. Further, genes encoding resistance to MLS (macrolide-
lincosamide-streptogramin) antimicrobials and aminoglycosides
are present in 14 and 19 isolates, respectively. These resistance
profiles illustrate the clinical relevance of the target strains. DNA
array hybridization also revealed the presence of bacterial toxin
genes, for example toxic shock toxin, leukocidins and enterotoxins.
The subset of analyzed isolates includes members of Epidemic
MRSA (EMRSA) clones Rhine-Hesse EMRSA/UK-EMRSA-3
(KS6, KS7), North German/Iberian EMRSA (UG9, UG10,
UG11, UG12), Lyon Clone/UK-EMRSA-2 (KS8, KS13) and
Berlin EMRSA (KS1, KS2, KS3, KS4, KS5, KS10, KS11, KS14).
These EMRSA clones are widespread and represent hospital-
acquired, carrying ‘staphylococcal chromosomal cassette’ (SCC)
mec element types I, II and III, as well as community-acquired,
carrying SCCmec types IV and V, MRSA [4,5]. In addition, all
pig, poultry and horse isolates are members of the emerging
MRSA clonal complex CC398, the most prevalent strain of
livestock-associated MRSA [6,7].
The host range was examined by spotting a tenfold serial
dilution of an ISP stock on a Mueller Hinton soft agar lawn
containing the potential host. The results were confirmed by a
plaque assay [8], which permitted to assess the efficiency of
plating, the relative phage titer on a bacterial strain compared to
the maximum titer observed. ISP infects 86% of the S. aureus
strains and none of the S. haemolyticus strains. All 34 human S. aureus
isolates were infected by ISP, while nine phage propagation strains
are insensitive to ISP infection. Interestingly, none of the pig
strains, but all other animal strains are sensitive to ISP infection.
Moreover, all but one of the S. aureus strains isolated from humans
Figure 1. Dendrogram of the 22 identified S. aureus and S. haemolyticus genotypes. The dendrogram was generated based on rep-PCR
patterns using a 98% similarity level. For each genotype, the representative strain and its fingerprint, the constituting isolates and the ISP sensitivity
are indicated.
doi:10.1371/journal.pone.0024418.g001
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and rabbits were infected by ISP with a high efficiency of plating,
whereas ISP displays a moderate efficiency of plating on six of the
sensitive phage propagation strains. In addition, the efficiency of
plating varies among the horse strains and is mainly low on the
poultry strains.
No correlation was observed between the 22 genotypes and ISP
sensitivity nor between the subset of characterized EMRSA clones
and ISP sensitivity. This is consistent with previous observations
made for fifteen Pseudomonas aeruginosa phages and their infection
patterns on 94 AFLP-typed host strains [9]. Nonetheless, the lytic
activity of ISP on all S. aureus strains isolated from patients is
promising for phage therapy purposes.
ISP infection parameters and emergence of bacterial
resistance
In addition to infectivity on agar plates, the capability of phage
ISP to adsorb on and subsequently infect S. aureus in a liquid
culture at 37uC was examined. The optical density at 600 nm of
Figure 2. Infection curves of Staphylococcus phage ISP. Three independent experiments of a non-infected culture and cultures infected with
MOI 0.1, 1 and 10 of S. aureus phage propagation strain 47 (A) and S. aureus subsp. aureus Rosenbach ATCC 6538 (B) are shown. Standard deviations
are indicated.
doi:10.1371/journal.pone.0024418.g002
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two S. aureus strains, phage propagation strain 47 and strain ATCC
6538, infected at different multiplicities of infection (MOI, the
ratio of phage particles to host cells) was monitored during a
certain time period. Both infection curves suggest a lytic cycle of
approximately 40 minutes. Interestingly, these killing curves
progress differently in time, as shown in Figure 2. Phage ISP is
able to completely lyse a culture of phage propagation strain 47 at
MOI 10 and for two hours this bacterial culture remains stable. In
contrast, S. aureus subsp. aureus Rosenbach ATCC 6538 is only
attenuated by ISP. At MOI 0.1, 1 and 10 the optical density at
600 nm stabilizes at 0.8, 0.5 and 0.3, respectively. Monitoring of
the number of free phages, adsorbed phages and viable bacteria
during the experiment hints at a lysis inhibition phenomenon (data
not shown). However, this long-delayed lysis mechanism for virion
yield maximizing could not be substantiated, since no increased
burst size was observed. For adsorption experiments, samples were
taken at fixed intervals and transferred to Mueller Hinton medium
supplemented with chloroform to lyse the remaining bacteria
[8,10]. Titration of the amount of nonadsorbed or reversibly
adsorbed phages showed that ISP adsorption occurs quite rapidly.
Approximately 50% of the ISP particles were bound within
1 minute and after 25 minutes a maximal adsorption of 85% was
reached (Figure S1).
For five human isolates, the rate at which ISP-resistant S. aureus
cells arise, was determined using the method of Beale [11] with
small adjustments. Therefore, 300 ml of bacterial cultures grown in
liquid Mueller Hinton medium was mixed with an excess of ISP
particles and plated out. Following 48 hours of incubation at
37uC, resistant colonies were counted. As with the P. aeruginosa
phage phiKMV [12], resistant colonies of various sizes were
observed. Interestingly, the ISP mutation rate (Table S2) varies
greatly between the different human isolates. S. aureus-resistant
colonies were observed a hundred times less frequent than phage-
resistant mutants of Streptomyces erythreus and Streptococcus thermophilus
in a similar experiment [13,14]. Additionally, ten randomly
selected resistant colonies of each human isolate were purified two
times by single-colony isolation and challenged again with ISP, to
verify their resistance. 44 out of 50 (88%) colonies appeared to
have acquired stable ISP resistance and hence the presented
mutation rates are slightly overestimated. The appearance of
phage-resistant mutants can be countered by using a complemen-
tary phage cocktail [15].
Biophysical stability and in vivo safety of ISP
To assess the stability of phage ISP for storage and mani-
pulation of the phage preparation as well as future animal testing
and therapeutic application, the survival of ISP was examined at
different temperatures and in the complete pH range. Phage ISP
was shown to be stable at 16uC, 37uC and 42uC, while freezing at
220uC and heating to 50uC reduced the phage titer with more
than two logarithmic units (Figure S2 (A)). Consequently, ISP
should be suited for the treatment of humans and animals,
including those with fever, and the decontamination of hospital
and farm environments. At pronounced acid (pH 1–3) or alkaline
(pH 11–13) conditions, ISP is completely inactivated (Figure S2
(B)). A pH of 4 resulted in a significant logarithmic reduction of the
titer, while ISP was stable between pH 5 and 9. This implies that
ISP will not survive in gastric acid (pH 1–2) and therefore cannot
Figure 3. Summary of the bio-informatical analysis of the phage ISP genome. (A) Representation of the genome of phage ISP. Predicted
proteins are indicated as bars, putative promoters are depicted as arrows and putative terminators as hair pins and the 4 tRNA’s are indicated in light
blue. The DNA polymerase and the endolysin, both interrupted by endonucleases, are colored red and orange respectively. Genes which were not
annotated in phage G1 are colored purple and genes mistakenly annotated in phage G1 in dark blue, additional genes in phage ISP are framed in red.
(B, C and D) Pairwise DNA homology of ISP and G1, ISP and K and ISP and Twort, compared using a sliding window of 50 bp.
doi:10.1371/journal.pone.0024418.g003
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be administered orally without manipulation. Blood has a neutral
pH and might thus provide a suitable environment for phages. To
exclude any negative effects of blood components on the viability
of phages in an ex vivo situation, ISP was incubated in rabbit blood
which was collected using a syringe rinsed with heparin and
transported in blood collection tubes (Microvette 500 Lithium
Heparin, SARSTEDT AG & Co., Nu¨mbrecht, Germany) con-
taining heparin to prevent blood clotting. No loss of infectivity was
observed, enabling potential intravenous phage administration.
In a preliminary study, the safety of ISP application was assessed
in hybrid albino rabbits following approval of the ethical
committee from the Faculty of Veterinary Medicine of Ghent
University (EC 2008_112, EC 2009_063). Nasal administration in
both nasal cavities as well as subcutaneous injection (1 ml syringe
and 26 G61/230 needle, Terumo International, Leuven, Belgium)
of 109 ISP particles was evaluated in three rabbits. In a parallel
experiment, three rabbits first received 3 mg/kg ranitidine
(ZantacH, Glaxo Smith Kline, Genval, Belgium) to inhibit gastric
acid secretion, followed by an oral dose of 109 ISP particles.
Subsequent daily clinical observation of the rabbits for at least 5
days revealed no adverse effects: the rabbits had a healthy
appetite, a normal rectal temperature and general condition and
no symptoms of illness. For ISP detection purposes after oral
administration, blood samples were obtained from the lateral ear
vein at several time points from 5 minutes till 12 hours after phage
administration using a 24 G63/40 catheter (Terumo Internation-
al). Following euthanasia with 0.5 ml/kg T61H (Intervet, Brussels,
Belgium), the faeces were collected and tissue samples were taken
from the liver, kidneys and spleen. ISP could not be detected in the
blood, the organs or the faeces of the rabbits.
Analysis of the ISP genome
ISP DNA was extracted from a CsCl-purified stock solution
(.109 pfu/ml) according to Sambrook and Russell [3]. Initial
sequencing was performed by shotgun sequencing of a library of
phage DNA in a pUC18 vector (Fermentas GmbH, St. Leon-Rot,
Germany) combined with primer walking until a single contig was
obtained. The linear double-stranded DNA of ISP with terminally
redundant ends and containing 138.339 bp (EMBL: FR852584)
was sequenced with an average redundancy of 6.7 and a coverage
of each base position with at least three sequencing reactions. ORF
Finder (http://www.ncbi.nlm.nih.gov/projects/gorf/), GeneMarkTM
[16] and BLASTx [17] were used to predict 215 open reading frames
(ORFs) (Figure 3), followed by manual verification. Further, the
predicted protein sequences were compared with known proteins and
putative functions were assigned using BLASTp [17] and HHpred
[18]. The nucleotide positions and additional information of all
predicted genes are shown in Table S3. Finally, four tRNA’s,
encoding Asp-tRNA, Phe-tRNA, Trp-tRNA and Met-tRNA, were
predicted in two non-coding regions of the genome using tRNAscan-
SE [19] and ARAGORN [20].
K [21], G1 and Twort [2] are the best-known representatives of
the ‘Twort-like viruses’ [22], myoviruses infecting gram-positive,
low G+C content bacteria, and are assumed to show promising
therapeutic potential. DNA homology with these phages was
examined with EMBOSS stretcher [23,24]. The genome of ISP is
99.5% identical to the 138.715 bp genome of phage G1 (Figure 3).
The mutual differences comprise small sequence deletions and
insertions which result in three extra hypothetical genes in ISP:
ORF92, ORF126 and ORF147. Seven genes of G1 were chosen
not to be annotated (ORF216, ORF247, ORF285, ORF309,
ORF311, ORF388 and ORF450), due to their gene location
integral in other genes or their questionable or absent Shine-
Dalgarno sequence. In contrast, five additional genes which were
not annotated in G1, ORF89, ORF103, ORF104, ORF140 and
ORF205, were added to the protein-coding part of the ISP
genome. At the nucleotide level, ISP displays 90.6% and 56.1%
homology with K (127.395 bp) and Twort (130.706 bp) respec-
tively, as shown in Figure 3. The differences with K are mainly
confined to a region of 25 kb containing only hypothetical genes,
while the variation between ISP and Twort is found throughout
their genomes. An overview of their homologous genes is
presented in Figure S3. In addition, several ISP genes were found
to be homologous with predicted genes of Listeria phage A511 and
Enterococcus phage phiEF24C, a ‘Twort-like virus’ and an orphan of
the Spounavirinae, respectively [22].
As described earlier for the phages K [21] and Twort [2], ISP
has its genes organized in three major modules encoding structural
proteins, components of the replication and transcription machin-
ery, and proteins responsible for cell lysis. Further, these phages
are typified by an overall conserved gene organization, insertions
and deletions, and the presence of unrelated genes between
Figure 4. Coomassie G-250 stained SDS-PAGE gel of the
structural proteome of phage ISP. On the left a low molecular
weight marker is shown. The numbers on the right correspond to the
analyzed gel pieces of which the identified proteins are given in Table 1.
Clearly visible protein bands are indicated with capital letters.
doi:10.1371/journal.pone.0024418.g004
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conserved genes [2]. For the purpose of phage therapy, the ISP
genome encodes no potential gene products resembling known
virulence or toxic proteins.
Phage ISP does not encode an RNA polymerase, implying its
dependency on the host RNA polymerase for transcription. In this
context, phage ISP encodes a sigma factor-binding polypeptide,
Gp47, first identified in phage G1 by Dehbi et al. [25]. This
polypeptide, which displays a growth-inhibitory effect when
overexpressed in S. aureus, is considered to be one of the crucial
components in the phage strategy to redirect the host RNA
polymerase to transcription of phage DNA.
Conserved regulatory motifs in the ISP genome were searched
using Nostradamus [26], PHIRE [27] and MEME/MAST [28]
and resulted in the prediction of 64 host-specific promoters
(Table S4). These putative promoters contain a variety of
conserved motifs and a spacer region with a length of 17 or 18
nucleotides. The 235 box sequence is well-conserved, whereas
more sequence variation is observed in the 210 box. Both the
235 box and the 210 box comprise six nucleotides and their
conservation is graphically analyzed with WebLogo [29] (Figure
S4). In addition, Palindrome [23] was used to detect 31 potential
factor-independent terminators, while the free energy of their
secondary structures was computed with Mfold [30] (Table S5).
Both the promoters and the terminators are equally distributed
over the ISP genome.
Proteome analysis of the ISP particle
In a next step, electrophoretic and mass spectrometric
techniques were used to elucidate the composition of the ISP
virion. Extraction of phage proteins from a CsCl-purified ISP
stock solution (.109 pfu/ml) was performed by methanol/
chloroform extraction (1:1:0.75, v/v/v). Following gel electropho-
resis, five major protein bands were clearly visualized with Simply
BlueTM Safe Stain (Invitrogen Ltd, Paisley, UK) (Figure 4).
Nonetheless the whole SDS-PAGE gel was fragmented and
subjected to tandem electrospray ionization-mass spectrometry
(ESI-MS/MS) on a LCQ Classic (ThermoFinnigan) equipped
with a nano-LC column switching system as described by Lavigne
et al. [31]. In 25 gel pieces, peptides of 22 phage proteins were
identified (Table 1). Thirteen of these proteins were already listed
as virion components and the structural function of Gp30, Gp38,
Gp40, Gp72 and Gp186 was confirmed by Eyer et al. in 2007 [32].
Six additional proteins, Gp2, Gp13, Gp16, Gp28, Gp31 and
Gp83, can be conferred to the group of structural proteins.
However, nine proteins, identified by Eyer et al. [32] using one-
dimensional and two-dimensional approaches, were not found in
the present study. Generally, the identified proteins were localized
in a major (Gp8–Gp40) and a minor (Gp70–Gp72) structural
region in the ISP genome.
Several ISP proteins were found throughout the entire SDS-
PAGE gel, illustrating their abundance in the phage virion. The
Table 1. Characteristics of the phage ISP ESI-MS/MS identified proteins.
ORF Band number
Molecular
mass (kDa)
Number of
identified
peptides
Sequence
coverage
(%) HHpred search e-value
K/G1
homologue1
Identification
method1
Gp2 19 30.6 1 8.4 / /
Gp8 8 64.0 12 27.4 Portal protein (HK97) 6.10E-41 ORF 41 (K) 2-DE
Gp11 1, 2, 4–13, 15–25 51.2 15 63.9 Capsid protein (HK97) 5.60E-01 ORF 44 (K) SDS-PAGE, 2-DE
Gp13 14 34.1 3 12.9 Tail fiber protein 1.60E+02 / /
Gp16 16 31.8 4 21.9 Baseplate hub assembly protein (T4) 1.50E+02 / /
Gp18 1, 2, 4–11, 13, 15–25 64.4 21 62.7 Tail sheath protein (T4) 0 ORF 49 (K) SDS-PAGE, 2-DE
Gp19 1, 22–25 15.9 5 54.2 Tail tube protein (T4) 1.00E+01 ORF 50 (K) SDS-PAGE, 2-DE
Gp26 1 143.9 1 1.4 Fibritin (T4) 3.10E-04 ORF 55 (K) SDS-PAGE
Gp28 15 34.6 2 10.5 Peptidoglycan hydrolase (Dp-1) 4.60E-11 / /
Gp30 16 29.3 4 24.3 ORF 59 (K) 2-DE
Gp31 21 19.9 1 6.3 / /
Gp32 16 26.6 4 25.6 Baseplate wedge subunit (T4) 2.00E-19 / /
Gp33 10, 15 39.1 3 6.9 Baseplate J-like protein (P2) 3.90E-42 ORF 62 (K) SDS-PAGE, 2-DE
Gp35 21, 22, 25 19.2 5 44.5 Baseplate structural protein (T4) 3.10E-04 ORF 64 (K) SDS-PAGE, 2-DE
Gp36 1–8, 15, 17, 24 129.1 33 40.5 ORF 65 (K) SDS-PAGE, 2-DE
Gp38 7, 8, 15–17 72.6 20 41.7 ORF 66 (K) 2-DE
Gp40 17 50.4 2 7.0 ORF 68 (K) SDS-PAGE, 2-DE
Gp70 1, 15–25 23.2 9 67.1 Major tail protein V (Lambda) 5.20E+01 ORF 95 (K) SDS-PAGE, 2-DE
Gp71 18, 21 17.8 3 42.4 Major tail protein V (Lambda) 4.60E-21 ORF 96 (K) SDS-PAGE, 2-DE
Gp72 25 7.8 2 28.0 ORF 189 (G1) 2-DE
Gp83 23 17.8 1 7.9 / /
Gp186 25 10.1 1 17.2 ORF 172 (G1) 2-DE
1Adjusted from Eyer et al. (2007).
For each gene product (Gp) the band number(s) (according to Figure 4), the molecular weight in kDa, the number of identified peptides (.99% protein identification
probability with manual validation), the protein sequence coverage in percent, the putative protein function according to HHpred and the corresponding e-value are
shown. Further, earlier identified homologous proteins of phage K or G1 and the corresponding identification method (SDS-PAGE/2-DE) are listed.
doi:10.1371/journal.pone.0024418.t001
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major capsid protein (Gp11), most likely present in the most
prominent protein band (C), exemplifies this phenomenon. The
abundant presence of these proteins may have hindered the
identification of less abundant structural proteins. According to the
molecular mass, band A and E contain Gp26 and Gp70
respectively. The band B protein (approximately 70 kDa) is
indefinable because both the molecular mass of Gp18 (64.4 kDa)
and Gp38 (72.6 kDa) approach its position. In protein band D
(30 kDa) no protein with a corresponding molecular mass was
found, but this band may represent the modified form of the tail
sheath protein (Gp18) linked to tail contraction as reported by
Chibani-Chennoufi et al. [33] and Eyer et al. [32].
To support the mass spectrometric identification of the 22
proteins in this analysis, a more profound database search using
HHpred was performed, in which a higher e-value was also taken
into account (Table 1). Interestingly, ISP virion proteins are
related to myoviral as well as siphoviral structural components.
Various identified ISP proteins show homology with structural
proteins of the E. coli phage T4. The contractile tail of this
myovirus consists of a contractile sheath, a tail tube and a
baseplate [34]. Gp16 is similar to a T4 protein responsible for the
formation of the central hub of the baseplate and Gp32 and
Gp35 are homologous to structural components of the T4
baseplate. Gp18 and Gp19 are related to the tail sheath protein
and the tail tube protein of phage T4, whereas Gp26 resembles
fibritin which attaches the tail fibers to the T4 particle. Five other
structural ISP proteins show homology with temperate E. coli
phages. The portal protein and capsid protein of ISP are related
to those of phage HK97, while Gp70 and Gp71 show similarity
to the major tail protein of phage Lambda and Gp33 is similar to
the baseplate protein J of phage P2. Finally, Gp13 and Gp28
were examined, revealing homology with the peptidoglycan
hydrolase of the pneumococcal phage Dp-1 and a phage tail fiber
domain, respectively. These findings support the hypothesis of
Chibani-Chennoufi et al. that the SPO1-related viruses share
structural homology with Siphoviridae more than with other
Myoviridae [33].
Discussion
By describing the composition, laboratory-based production
and quality control of an experimental phage cocktail containing
S. aureus phage ISP, Merabishvili et al. [1] support the practical re-
introduction of phage therapy in Western medicine. The
microbiological and molecular characterization of phage ISP in
the present report is a necessary step in the medical exploitation of
the antibacterial potential of BFC-1. The presented host range
screening including clinically relevant MRSA strains, the deter-
mination of the infection parameters and the assessment of the ISP
virion stability (temperature, pH, blood components) contribute to
the further development of the therapeutic application of ISP.
Moreover, phage ISP can be safely administered orally, in the nose
and through subcutaneous injection. In case of oral application,
ISP did not reach the blood, the faeces or the organs. In addition,
the genome analysis of ISP, which revealed no toxic or virulence-
associated genes, emphasizes the mutual similarity between the
‘Twort-like viruses’, which remains the only known genus of
virulent S. aureus-infecting viruses so far.
Supporting Information
Figure S1 Adsorption curve of phage ISP on S. aureus
subsp. aureus Rosenbach ATCC 6538. The proportion of
the amount of non-adsorbed phages to the amount of phages used
for infection, based on three independent experiments, is shown
and standard deviations are indicated.
(TIF)
Figure S2 Biophysical stability of phage ISP. The
logarithmic drop in infectious ISP particles after 24 hours of
incubation at different pH levels (A) and at different temperatures
(B) is shown. Three independent experiments were performed,
standard deviations are indicated.
(TIF)
Figure S3 Summary of the common genes of the phages
ISP, K and Twort. The genome of ISP contains 83 genes which
have homologous counterparts in K and Twort. Further, ISP
shares 85 and 1 additional homologous genes with K and Twort
repectively. In contrast, K and Twort have no additional common
genes. Forty-one ISP genes absent in phage K are generally
organized in three major blocks and situated downstream the
DNA replication and transcription module. The differences
between ISP and Twort are located througout their whole genome
sequence. ISP and Twort have 41 and 109 unique genes
respectively and their common genes are about 70% homologous.
(TIF)
Figure S4 Sequence logo of the conserved motifs of the
promoters of phage ISP. The conservation of the 235 box (A)
and the 210 box (B) of the 65 promoters predicted in the genome
of ISP is depicted. The height of each stack designates the
sequence conservation at that position (measured in bits), while the
height of the symbols within each stack indicates the relative
frequency of the nucleotide at that position.
(TIF)
Table S1 Overview of the host range of Staphylococcus
phage ISP. The clarity of the lysis zones after spotting several
phage dilutions was scored as clear and turbid and the dilution on
which lysis spots and individual plaques appeared was taken into
account. These observations in combination with a verifying
plaque assay were used to differentiate between sensitive (+) and
insensitive (2) to ISP infection on one hand and a low, moderate
and high efficiency of plating on the other hand. For each isolate,
the species, the origin, the sensitivity to ISP infection and the
efficiency of plating is given. For 33 isolates the presence (+) or
absence (2) of genes encoding resistance to methicillin, MLS3
antimicrobials, aminoglycosides and tetracycline, as well as the
presence or absence of penicillinase is shown.
(DOCX)
Table S2 Mutation rate for ISP resistance. For five human
S. aureus isolates, the mutation rate conferring ISP resistance was
calculated by dividing the number of resistant colonies by the
number of bacterial cells at the time of ISP application. Based on
five individual experiments, the mean values and corresponding
standard deviations are indicated.
(DOCX)
Table S3 Features of the predicted ORFs of phage ISP.
For each predicted ORF the start and stop position in the genome,
the length of the corresponding gene product in amino acids, the
reading frame, the start and stop codon, the putative protein function
and the corresponding prediction program and e value are shown.
(DOCX)
Table S4 Predicted host-specific promotors of phage
ISP. For each promotor the strand, the start and stop position in
the genome, the 235 box, the spacer region, the 210 box and the
length of the spacer region are given.
(DOCX)
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Table S5 Predicted factor-independent terminators of
phage ISP. For each terminator the strand, the start and stop
position in the genome, the free energy of their secundary
structure and the sequence of the regulatory element (the
palindromic sequence is underlined) are given.
(DOCX)
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